Quipt Home Medical Corp

Quipt Home Medical Corp. engages in the provision of in-home monitoring and disease management services including end-to-end respiratory solutions. Its services include sleep apnea and pap treatment, home ventilation, equipment solutions, daily and ambulatory aides, power mobility, respiratory equipment rental, and oxygen therapy. The company was founded on March 5, 1993 and is headquartered in Wilder, KY.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Quipt Home Medical Corp. engages in the provision of in-home monitoring and disease management services including end-to-end respiratory solutions. Its services include sleep apnea and pap treatment, home ventilation, equipment solutions, daily and ambulatory aides, power mobility, respiratory equipment rental, and oxygen therapy. The company was founded on March 5, 1997 and is headquartered in Wilder, KY.

CINCINNATI, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, today announced that it will host its Fiscal Q3 2022 earnings conference call and audio webcast on Tuesday, August 16, 2022 at 10:00 a.m. (EDT).

Quipt Home Medical Announces Date and Time for Fiscal Q3 2022 Conference Call and Audio Webcast

Quipt recently signed a national insurance contract with UnitedHealthcare, helping to accelerate its strategic growth plan. Shortly after, the company inked a deal with another industry giant, Cardinal Health, to sell Cardinal's disposable medical equipment and supplies nationwide.

Quipt Business Progresses, Stock Price Should Soon Follow

Contract for Supply of Disposable Medical Supplies Bolsters Interconnected Healthcare Network During National Expansion Contract for Supply of Disposable Medical Supplies Bolsters Interconnected Healthcare Network During National Expansion

Quipt Home Medical Announces Supply Contract with Cardinal Health Further Expanding Continuum of Care

Webcasted Presentation to be Held Thursday August 11th Webcasted Presentation to be Held Thursday August 11th

Quipt Home Medical to Participate at the 42nd Annual Canaccord Growth Conference on August 8th - 11th

Acquisition of Hometown Medical, LLC Significantly Enhances Presence in Mississippi Acquisition of Hometown Medical, LLC Significantly Enhances Presence in Mississippi

Quipt Surpasses 200,000 Active Patients Adding Approximately $7 Million in Annualized Revenues, and Anticipated $1.4 Million of Adjusted EBITDA Post Integration

Quipt Home Medical is at a turning point in terms of profitability and the market looks to have brushed past this in favour of systemic risks. The forward equity premium from Quipt looks attractive as the market continues to reward bottom-line fundamentals over top-line growth.

Quipt: At A Turning Point, Seeking 40% Return Objective

Expands Referring Physician Network to Over 20,600 and Active Patient Base to Over 190,000 Expands Referring Physician Network to Over 20,600 and Active Patient Base to Over 190,000

Quipt Enters Louisiana Adding Approximately $6.5 Million in Annualized Revenues, and Anticipated $1.3 Million of Adjusted EBITDA (post integration) with Acquisition of Access Respiratory Homecare, LLC

Acquisition Adds $3.2 Million in Annualized Revenues, Over 650K Adjusted EBITDA Post Integration Acquisition Adds $3.2 Million in Annualized Revenues, Over 650K Adjusted EBITDA Post Integration

Quipt Expands in California with Acquisition of NorCal Respiratory Reaching 90 Locations Nationwide

CINCINNATI, June 06, 2022 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, is very pleased to announce it is on a preliminary list dated June 3, 2022 issued by the Russell Microcap Index to join the Russell Microcap Index at the conclusion of the 2022 Russell indexes annual reconstitution, effective after the U.S. market opens on June 27, 2022.

Quipt Home Medical on Preliminary List to Join Russell Microcap® Index

Presentation on Tuesday, June 7th 12:00 PM PT/ 3:00 PM ETWestlake Village, California--(Newsfile Corp. - May 19, 2022) - Quipt Home Medical Corp. (NASDAQ: QIPT) (TSXV: QIPT) (the "Company" or "Quipt"), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, announced today that it will be presenting at the 12th annual Invitational on Tuesday, June 7th 12:00 PM PT at the Four Seasons Westlake Village.Greg Crawford, Chairman and Chief Executive Officer, will be giving the presentation."We are proud to be...

Quipt Home Medical to Present at the LD Micro Invitational

Quipt Home Medical Corp. (NASDAQ:QIPT ) Q2 2022 Earnings Conference Call May 17, 2022 10:00 AM ET Company Participants Greg Crawford - Chairman and CEO Hardik Mehta - CFO Conference Call Participants Doug Cooper - Beacon Securities Sepehr Manochehry - Eight Capital Tania Armstrong-Whitworth - Canaccord Genuity Raul Sarugaser - Raymond James Paul Stewardson - IA Capital Markets Justin Keywood - Stifel Stefan Quenneville - Echelon Capital Markets Operator Thank you for standing by. This is the conference operator.

Quipt Home Medical Corp. (QIPT) CEO Greg Crawford on Q2 2022 Results - Earnings Call Transcript

Quipt Home Medical Corp. (QIPT) delivered earnings and revenue surprises of 366.67% and 4.27%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Quipt Home Medical Corp. (QIPT) Tops Q2 Earnings Estimates

Posts Revenue Growth of 38% and Adjusted EBITDA Growth of 31%

Quipt Home Medical Reports Record Second Quarter Fiscal 2022 Financial Results

Quipt (QIPT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Should You Buy Quipt (QIPT) Ahead of Earnings?

CINCINNATI, May 03, 2022 (GLOBE NEWSWIRE) --  Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT) (TSXV: QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, today announced that it will host its Fiscal Q2 2022 earnings conference call and audio webcast on Tuesday, May 17, 2022 at 10:00 a.m. (EST).

Quipt Home Medical Announces Date and Time for Fiscal Q2 2022 Conference Call and Audio Webcast

National Contract Provides Access to Patients Across the United States and Provides Opportunity to Accelerate Long Term Strategic Growth Plans National Contract Provides Access to Patients Across the United States and Provides Opportunity to Accelerate Long Term Strategic Growth Plans

Quipt Home Medical Announces National Insurance Contract with a Top 5 Largest Health Insurer in the United States

Acquisition Adds $7.5 Million in Annualized Revenues, 20% Adjusted EBITDA Margin Post Integration, and Over 10,000 Active Patients Acquisition Adds $7.5 Million in Annualized Revenues, 20% Adjusted EBITDA Margin Post Integration, and Over 10,000 Active Patients

Quipt Accelerates National Expansion Efforts with Acquisition of Multi State Operator - Good Night Medical - Significantly Bolstering Commercial Contract Portfolio

QIPT shares held up well through the January small cap bloodbath but took a nosedive in February 2022. I believe this sharp and sudden drop in share price is directly related to a specific balance sheet headwind the company faces - convertible debentures.

Quipt Convertible Debenture Hedging Provides An Incredible Opportunity

Sidoti Webcasted Presentation to be Held Wednesday March 23rd Sidoti Webcasted Presentation to be Held Wednesday March 23rd

Quipt Home Medical to Participate at the Sidoti Virtual Investor Conference On March 23rd – 24th

Posts Revenue Growth of 30% and Adjusted  EBITDA Growth of 16%

Quipt Home Medical Reports Record First Quarter Fiscal 2022 Financial Results

InfuSystem Hlds

Inuvo

Smith Micro Software

TechPrecision Corp

The market dropped precipitously in January 2022, with the Russell 2000 down by nearly 10%. Like many sudden market “corrections,” this one “threw out the baby with the bath water,” meaning virtually all stocks were hammered regardless of their underlying fundamentals.

January Correction Leads To Attractive Opportunities

Mr. Brian J. Wessel Appointed to Board of Directors and Chair of Audit Committee Mr. Brian J. Wessel Appointed to Board of Directors and Chair of Audit Committee

Quipt Home Medical Announces New Independent Board Member

Quipt Home Medical Corp. (QIPT) CEO Greg Crawford on Q4 2021 Results - Earnings Call Transcript

CINCINNATI, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, is pleased to announce that, as a result of the filing of its annual financial statements and management discussion & analysis for the financial years ended September 30, 2021 and 2020, and the CEO and CFO certificates, on January 27, 2022, the management cease trade order issued by the British Columbia Securities Commission (“BCSC”) on December 30, 2021 has been revoked by the BCSC effective January 28, 2022.

Quipt Announces Revocation of Management Cease Trade Order

POSTS REVENUE GROWTH OF 41% AND ADJUSTED EBITDA GROWTH OF 38% SURPASSING PRELIMINARY GUIDANCE

News for Quipt Home Medical Corp Stock (QIPT)